BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS
643 results:

  • 1. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma.
    Chen J; Zhou J; Cheng F; Chen D; Guan F; Zhang E; He J; Cai Z; Zhao Y
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):181. PubMed ID: 38587664
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines.
    Zeissig MN; Hewett DR; Mrozik KM; Panagopoulos V; Wallington-Gates CT; Spencer A; Dold SM; Engelhardt M; Vandyke K; Zannettino ACW
    Leuk Res; 2024 Apr; 139():107469. PubMed ID: 38479337
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Primary thyroid lymphoma: a case series.
    Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
    J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Small cell osteosarcoma versus fusion-driven round cell sarcomas of bone: retrospective clinical, radiological, pathological, and (epi)genetic comparison with clinical implications.
    Hiemcke-Jiwa LS; Sumathi VP; Baumhoer D; Smetsers SE; Haveman LM; van Noesel MM; van Langevelde K; Cleven AHG; van de Sande MAJ; Ter Horst SAJ; Kester LA; Flucke U
    Virchows Arch; 2024 Mar; 484(3):451-463. PubMed ID: 38332052
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Successful cord blood transplantation for refractory gamma-delta hepatosplenic T-cell lymphoma developed during treatment of Crohn's disease].
    Saito A; Nara M; Fujishima T; Kuroki W; Yamashita T; Kobayashi T; Ikeda S; Kitadate A; Kameoka Y; Takahashi N
    Rinsho Ketsueki; 2024; 65(1):41-46. PubMed ID: 38311388
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Sclerosing Epithelioid Fibrosarcoma.
    Warmke LM; Yu W; Meis JM
    Surg Pathol Clin; 2024 Mar; 17(1):119-139. PubMed ID: 38278601
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Long-term outcomes with HLX01 (HanliKang
    Qin Y; Song Y; Wang D; Bai O; Feng J; Sun X; Qiu L; Yang J; Yang Y; Wang Z; Hu J; Wang H; Su H; Jin Z; Qian W; Jin C; Zhang M; Yu D; Liu L; Chen G; Li Y; Sun T; Jin J; Bao H; Du X; Zhou H; Fu G; Shi Y
    BMC Cancer; 2024 Jan; 24(1):124. PubMed ID: 38267866
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Incidence and risk factors for febrile neutropenia of patients with diffuse large B-cell lymphoma receiving R-chop-21 in China.
    Zheng W; Chen Z; Zhu S; Cheng L; Hu Y; Yang Y; Tan M; Ning H; Guan L
    Support Care Cancer; 2023 Dec; 32(1):43. PubMed ID: 38200251
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Vascular Neoplasms With NFATC1/C2 Gene Alterations : Expanding the Clinicopathologic and Molecular Characteristics of a Distinct Entity.
    Dashti NK; Perret R; Balzer B; Naous R; Michal M; Dermawan JK; Antonescu CR
    Am J Surg Pathol; 2024 Apr; 48(4):487-496. PubMed ID: 38189436
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature.
    Bradová M; Mosaieby E; Michal M; Vaněček T; Ing SK; Grossmann P; Koshyk O; Kinkor Z; Laciok Š; Nemcová A; Straka Ľ; Farkas M; Michal M; Švajdler M
    Histopathology; 2024 Apr; 84(5):776-793. PubMed ID: 38114270
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Uncovering the Genetic Etiology of Inherited bone Marrow Failure Syndromes Using a Custom-Designed Next-Generation Sequencing Panel.
    Lin F; Cao K; Chang F; Oved JH; Luo M; Fan Z; Schubert J; Wu J; Zhong Y; Gallo DJ; Denenberg EH; Chen J; Fanning EA; Lambert MP; Paessler ME; Surrey LF; Zelley K; MacFarland S; Kurre P; Olson TS; Li MM
    J Mol Diagn; 2024 Mar; 26(3):191-201. PubMed ID: 38103590
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes.
    Noerenberg D; Briest F; Hennch C; Yoshida K; Hablesreiter R; Takeuchi Y; Ueno H; Staiger AM; Ziepert M; Asmar F; Locher BN; Toth E; Weber T; Amini RM; Klapper W; Bouzani M; Poeschel V; Rosenwald A; Held G; Campo E; Ishaque N; Stamatopoulos K; Kanellis G; Anagnostopoulos I; Bullinger L; Goldschmidt N; Zinzani PL; Bödör C; Rosenquist R; Vassilakopoulos TP; Ott G; Ogawa S; Damm F
    J Clin Oncol; 2024 Feb; 42(4):452-466. PubMed ID: 38055913
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Circular RNA CircSATB2 facilitates osteosarcoma progression through regulating the miR-661/fus-mediated mRNA of ZNFX1.
    Wang Z; She D; Liu L; Hua X; Zhu H; Yu L; Wang H; Zhu Y; Fan G; Wang Y; Xu M; Zhou G
    Cell Signal; 2024 Feb; 114():110977. PubMed ID: 37984605
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The impact of chop versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study.
    Pedersen MA; Gormsen LC; Jakobsen LH; Eyre TA; Severinsen MT; Baech J; Dann EJ; Knapp A; Sahin D; Vestergaard P; El-Galaly TC; Jensen P
    Br J Haematol; 2024 Apr; 204(4):1271-1278. PubMed ID: 37957542
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
    Huang F; Ruan Y; He X; Lian H; Yang J
    World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cutaneous rhabdomyosarcoma with fus::TFCP2 fusion: A case report emphasizing early detection.
    Demirkesen C; Danyeli AE; Yıldız P; Ertekin SS; Yılmaz B; Karahan Sİ; Bahrami A
    J Cutan Pathol; 2023 Dec; 50(12):1059-1064. PubMed ID: 37669767
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Intraosseous Spindle Cell Rhabdomyosarcoma with
    Smith BF; Doung YC; Beckett B; Corless CL; Davis LE; Davis JL
    Cancer Invest; 2023 Sep; 41(8):704-712. PubMed ID: 37668330
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. DNA Methylation Profiling Distinguishes Adamantinoma-Like Ewing Sarcoma From Conventional Ewing Sarcoma.
    Fritchie KJ; Ameline B; Andrei V; Griffith C; Shah AA; Dermawan JK; Trucco M; Budd T; Thangaiah JJ; Molligan J; Whaley RD; Magliocca K; Azzato E; van Zante A; Jo V; Xu B; Bishop JA; Rooper L; Baumhoer D
    Mod Pathol; 2023 Nov; 36(11):100301. PubMed ID: 37567448
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Successes and Challenges in Taming the Beast: Cytotoxic Immune Effectors in Amyotrophic Lateral Sclerosis.
    Kaur K; Chen PC; Ko MW; Mei A; Huerta-Yepez S; Maharaj D; Malarkannan S; Jewett A
    Crit Rev Immunol; 2023; 43(1):1-11. PubMed ID: 37522557
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Adamantinoma-like Ewing Sarcoma (ALES) May Harbor fus Rearrangements : A Potential Diagnostic Pitfall.
    Palsgrove DN; Foss RD; Yu W; Garcia J; Rooper LM; Rekhtman N; Antonescu C; Gagan J; Agaimy A; Bishop JA
    Am J Surg Pathol; 2023 Nov; 47(11):1243-1251. PubMed ID: 37494548
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 33.